Despite in vitro and in vivo studies apprise evidence to relation between GH-IGF-1 and cancer risk and the concern for a possible role in cancer progression by GH administration, a recent meta-analysis suggests that GH replacement therapy reduces cancer risk in adults GHD [34]. Here, IGF1 is linked to cancer.